Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models
Molecules · 2023
DOI: 10.3390/molecules28072941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Shane Forde und 5 weiteren Autor:innen. Beteiligte Einrichtung: UCD School of Veterinary Medicine, UCD Conway Institute, University College Dublin, Belfield, D04 V1W8 Dublin, Ireland. Hauptthemen laut MEDLINE: Nanoparticles, Selenium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Department of Agriculture, Food and Marine., Irish Department of Agriculture, Food and Marine.
Abstract (Originalsprache)
Selenium methionine (SeMet) is an essential micronutrient required for normal body function and is associated with additional health benefits. However, oral administration of SeMet can be challenging due to its purported narrow therapeutic index, low oral bioavailability, and high susceptibility to oxidation. To address these issues, SeMet was entrapped in zein-coated nanoparticles made from chitosan using an ionic gelation formulation. The high stability of both the SeMet and selenomethionine nanoparticles (SeMet-NPs) was established using cultured human intestinal and liver epithelial cells, rat liver homogenates, and rat intestinal homogenates and lumen washes. Minimal cytotoxicity to Caco-2 and HepG2 cells was observed for SeMet and SeMet-NPs. Antioxidant properties of SeMet were revealed using a Reactive Oxygen Species (ROS) assay, based on the observation of a concentration-dependent reduction in the build-up of peroxides, hydroxides and hydroxyl radicals in Caco-2 cells exposed to SeMet (6.25–100 μM). The basal apparent permeability coefficient (Papp) of SeMet across isolated rat jejunal mucosae mounted in Ussing chambers was low, but the Papp was increased when presented in NP. SeMet had minimal effects on the electrogenic ion secretion of rat jejunal and colonic mucosae in Ussing chambers. Intra-jejunal injections of SeMet-NPs to rats yielded increased plasma levels of SeMet after 3 h for the SeMet-NPs compared to free SeMet. Overall, there is potential to further develop SeMet-NPs for oral supplementation due to the increased intestinal permeability, versus free SeMet, and the low potential for toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCD School of Veterinary Medicine, UCD Conway Institute, University College Dublin, Belfield, D04 V1W8 Dublin, Ireland.
- Environmental Science and Health Institute, Technological University Dublin, Grangegorman, D07 EWV4 Dublin, Ireland.
- FOCAS Research Institute, Technological University Dublin, Camden Row, Dublin 8, D08 CKP1 Dublin, Ireland.
ORCID-Profile: David J Brayden, Hugh J Byrne, Jesus M Frías, Sinéad M Ryan
Förderung
- Irish Department of Agriculture, Food and Marine.
- Irish Department of Agriculture, Food and Marine
Zitieren
APA
Forde, S., Vozza, G., Brayden, D. J., Byrne, H. J., Frías, J. M., & Ryan, S. M. (2023). Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models. Molecules. https://doi.org/10.3390/molecules28072941
Vancouver
Forde S, Vozza G, Brayden DJ, Byrne HJ, Frías JM, Ryan SM. Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models. Molecules. 2023. doi:10.3390/molecules28072941
BibTeX
@article{Forde2023,
author = {Forde, Shane and Vozza, Giulianna and Brayden, David J and Byrne, Hugh J and Frías, Jesus M and Ryan, Sinéad M},
title = {Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28072941}
}
EUVIMED